• Home
  • About
    • About I-MAK
    • Our Work
    • I-Mak Directors
    • Board Of Directors
    • Advisory Board
    • Partners
    • Contact
  • Our Cases
    • Our Cases
    • FAQs
    • Lopinavir/Ritonavir
    • Abacavir Sulfate
    • Nevirapine Hemihydrate
    • Oseltamivir
    • Tenofovir
  • Testimonials
  • Media Center
    • Video/Audio
    • News Releases
    • Media Articles
    • Bios & Photos
  • Resources
    • I-MAK Blog
    • Archive
    • Publications
    • Presentations
    • Roadmap
    • Patent Landscapes
    • Pharmaceutical Patent Decisions
    • Patent Information
    • IP & Health Links
  • Donate

I-MAK

Initiative For Medicines, Access & Knowledge
  • Home
  • About
    • About I-MAK
    • Our Work
    • I-Mak Directors
    • Board Of Directors
    • Advisory Board
    • Partners
    • Contact
  • Our Cases
    • Our Cases
    • FAQs
    • Lopinavir/Ritonavir
    • Abacavir Sulfate
    • Nevirapine Hemihydrate
    • Oseltamivir
    • Tenofovir
  • Testimonials
  • Media Center
    • Video/Audio
    • News Releases
    • Media Articles
    • Bios & Photos
  • Resources
    • I-MAK Blog
    • Archive
    • Publications
    • Presentations
    • Roadmap
    • Patent Landscapes
    • Pharmaceutical Patent Decisions
    • Patent Information
    • IP & Health Links
  • Donate

  • Home
  • About
    • About I-MAK
    • Our Work
    • I-Mak Directors
    • Board Of Directors
    • Advisory Board
    • Partners
    • Contact
  • Our Cases
    • Our Cases
    • FAQs
    • Lopinavir/Ritonavir
    • Abacavir Sulfate
    • Nevirapine Hemihydrate
    • Oseltamivir
    • Tenofovir
  • Testimonials
  • Media Center
    • Video/Audio
    • News Releases
    • Media Articles
    • Bios & Photos
  • Resources
    • I-MAK Blog
    • Archive
    • Publications
    • Presentations
    • Roadmap
    • Patent Landscapes
    • Pharmaceutical Patent Decisions
    • Patent Information
    • IP & Health Links
  • Donate
Search

 

Subscribe Via RSS

 

Or Email

Enter your email address:

Delivered by FeedBurner

 

 

 

 

"The lives of millions of the world's poorest citizens critically depend on access to affordable medicines... I-MAK's innovative approach to addressing this crisis represents no less than a wave of hope for patients across the globe."

Dr.Jim Yong Kim, MD PhD, former Director of HIV/AIDS for the World Health Organisation

Except for publications commissioned or published by third parties all content on this site is licensed under a Creative Commons Attribution 3.0 License